Agilent Technologies, Inc.
https://www.agilent.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Agilent Technologies, Inc.
Keeping Track: Good News For Deciphera, BMS And Clovis; Bad News For bluebird/BMS, Blueprint And Tonix
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Hello NMPA: China Approval For Astellas's Xtandi, Keytruda Set For Fourth Indication
Astellas’s Xtandi gets its latest approval in China, where Merck’s Keytruda is set for another win.
Global Device Approvals Snapshot: 11-17 June 2019
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker, including a PMA supplement for Agilent’s PD-L1 IHC 22C3 pharmDx companion diagnostic for Merck’s Keytruda (pembrolizumab), an anti-PD-1 drug, for patients with head and neck squamous cell carcinoma. The US FDA also approved a supplement for the Cochlear Nucleus Profile Plus Series Cochlear Implant, designed to be safe with magnetic resonance imaging.
Global Device Approvals, Weekly Snapshot: Aug. 13-19, 2018
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker. This week, two Health Canada approvals, and more.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- In Vitro Diagnostics
- Laboratory Testing Services
- Research, Analytical Equipment & Supplies
-
Pharmaceuticals
- Chiral Chemistry
-
Medical Devices
- Diagnostic Equipment & Supplies
- Other Names / Subsidiaries
-
- ACEA Biosciences
- Advanced Analytical Technologies
- BioTek
- Cartagenia
- Dako
- J&W Scientific Inc.
- Lasergen, Inc.
- Luxcel Biosciences
- Multiplicom
- Seahorse Bioscience
- Silicon Genetics
- Ultra Scientific